GIP: an inconsequential incretin or not?

Richard E Pratley
Author Information

Abstract

No abstract text available.

References

  1. Diabetes Care. 2010 Jul;33(7):1561-6 [PMID: 20200305]
  2. Diabet Med. 2008 Nov;25(11):1268-75 [PMID: 19046215]
  3. Diabetologia. 2009 Feb;52(2):199-207 [PMID: 19037628]
  4. Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1269-74 [PMID: 19351807]
  5. J Clin Invest. 1993 Jan;91(1):301-7 [PMID: 8423228]
  6. Cell Metab. 2006 Mar;3(3):153-65 [PMID: 16517403]
  7. Metabolism. 2010 Apr;59(4):502-11 [PMID: 19846181]
  8. Diabetes. 2010 Jun;59(6):1445-50 [PMID: 20332343]
  9. Diabetologia. 1986 Jan;29(1):46-52 [PMID: 3514343]
  10. Nat Clin Pract Endocrinol Metab. 2008 Nov;4(11):606-7 [PMID: 18725906]
  11. Rev Diabet Stud. 2008 Summer;5(2):73-94 [PMID: 18795210]
  12. Diabetologia. 1997 Feb;40(2):205-11 [PMID: 9049482]

MeSH Term

Diabetes Mellitus, Type 2
Gastric Inhibitory Polypeptide
Glucose Intolerance
Humans
Incretins

Chemicals

Incretins
Gastric Inhibitory Polypeptide

Word Cloud

Created with Highcharts 10.0.0GIP:inconsequentialincretinnot?

Similar Articles

Cited By